35.06
Schlusskurs vom Vortag:
$35.16
Offen:
$35.26
24-Stunden-Volumen:
14,978
Relative Volume:
0.04
Marktkapitalisierung:
$1.11B
Einnahmen:
$566.77M
Nettoeinkommen (Verlust:
$48.16M
KGV:
29.46
EPS:
1.19
Netto-Cashflow:
$274.29M
1W Leistung:
-2.82%
1M Leistung:
-9.36%
6M Leistung:
+16.55%
1J Leistung:
-6.04%
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Firmenname
Collegium Pharmaceutical Inc
Sektor
Telefon
781-713-3699
Adresse
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Vergleichen Sie COLL mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
COLL
Collegium Pharmaceutical Inc
|
35.14 | 1.10B | 566.77M | 48.16M | 274.29M | 1.19 |
![]()
ZTS
Zoetis Inc
|
141.30 | 63.20B | 9.39B | 2.62B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.82 | 47.56B | 29.96B | 957.25M | 4.77B | 0.304 |
![]()
HLN
Haleon Plc Adr
|
8.7888 | 39.84B | 14.26B | 1.98B | 2.47B | 0.4347 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.82 | 22.31B | 16.70B | -157.13M | 1.19B | -0.155 |
![]()
UTHR
United Therapeutics Corp
|
430.02 | 19.63B | 2.99B | 1.21B | 1.13B | 25.06 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-01-10 | Hochstufung | Needham | Hold → Buy |
2024-07-30 | Hochstufung | H.C. Wainwright | Neutral → Buy |
2024-06-07 | Hochstufung | Jefferies | Hold → Buy |
2024-05-10 | Herabstufung | Needham | Buy → Hold |
2024-05-10 | Herabstufung | Piper Sandler | Overweight → Neutral |
2024-01-04 | Herabstufung | Jefferies | Buy → Hold |
2023-08-25 | Bestätigt | Needham | Buy |
2023-05-02 | Fortgesetzt | Jefferies | Buy |
2022-08-08 | Herabstufung | H.C. Wainwright | Buy → Neutral |
2022-02-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
2021-08-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
2021-01-11 | Bestätigt | H.C. Wainwright | Buy |
2020-07-14 | Eingeleitet | BWS Financial | Sell |
2020-05-27 | Eingeleitet | Guggenheim | Neutral |
2020-02-19 | Fortgesetzt | Jefferies | Buy |
2019-10-30 | Bestätigt | Needham | Buy |
2019-05-03 | Fortgesetzt | H.C. Wainwright | Buy |
2019-04-12 | Fortgesetzt | Janney | Buy |
2019-03-20 | Eingeleitet | SunTrust | Hold |
2019-01-16 | Bestätigt | Needham | Buy |
2018-03-08 | Bestätigt | H.C. Wainwright | Buy |
2018-02-07 | Bestätigt | Needham | Buy |
2017-12-05 | Bestätigt | Needham | Buy |
2017-09-11 | Eingeleitet | H.C. Wainwright | Buy |
2017-05-11 | Bestätigt | Needham | Buy |
2016-09-13 | Eingeleitet | Gabelli & Co | Buy |
2015-06-01 | Eingeleitet | Jefferies | Buy |
2015-06-01 | Eingeleitet | Needham | Buy |
2015-06-01 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Collegium Pharmaceutical Inc Aktie (COLL) Neueste Nachrichten
Branded Pharmaceuticals Stocks Q2 Highlights: Collegium Pharmaceutical (NASDAQ:COLL) - TradingView
Collegium Pharmaceutical, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? - sharewise.com
Long term hold vs stop loss in Collegium Pharmaceutical Inc.Trade Risk Assessment & Daily Technical Forecast Reports - newser.com
Can Collegium Pharmaceutical Inc. rally from current levelsEarnings Beat & Reliable Trade Execution Plans - newser.com
Will Collegium Pharmaceutical Inc. bounce back from current supportJuly 2025 Breakouts & Precise Trade Entry Recommendations - newser.com
Order flow analysis tools used on Collegium Pharmaceutical Inc.2025 Stock Rankings & AI Enhanced Execution Alerts - newser.com
Goldman Sachs Group Inc. Sells 44,391 Shares of Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Can volume confirm reversal in Collegium Pharmaceutical Inc.Market Movement Recap & AI Enhanced Trading Signals - newser.com
Real time scanner hits for Collegium Pharmaceutical Inc. explainedJuly 2025 Breakouts & Free Community Consensus Stock Picks - newser.com
Collegium Pharmaceutical Inc. stock trendline breakdownMarket Performance Report & Advanced Technical Signal Analysis - newser.com
Collegium Pharmaceutical (NASDAQ:COLL) Trading Down 4.7%Here's Why - MarketBeat
Harbor Capital Advisors Inc. Sells 2,957 Shares of Collegium Pharmaceutical, Inc. $COLL - Defense World
Price action breakdown for Collegium Pharmaceutical Inc.Portfolio Risk Report & Weekly Chart Analysis and Trade Guides - newser.com
Can trapped investors hope for a rebound in Collegium Pharmaceutical Inc.Weekly Trade Recap & Breakout Confirmation Alerts - newser.com
Top chart patterns to watch in Collegium Pharmaceutical Inc.Breakout Watch & Weekly Chart Analysis and Guides - newser.com
Signal Recap: Is VEEAW exposed to political risk2025 Earnings Surprises & Weekly Market Pulse Updates - khodrobank.com
Heatmap analysis for Collegium Pharmaceutical Inc. and competitors2025 Trading Volume Trends & Safe Entry Trade Reports - newser.com
Aug Summary: What is the target price for Collegium Pharmaceutical Inc stockJuly 2025 EndofMonth & Real-Time Volume Surge Alerts - khodrobank.com
How to integrate Collegium Pharmaceutical Inc. into portfolio analysis toolsQuarterly Portfolio Review & Reliable Intraday Trade Plans - newser.com
Historical volatility pattern of Collegium Pharmaceutical Inc. visualized2025 Institutional Moves & Fast Exit and Entry Strategy Plans - newser.com
Is Collegium Pharmaceutical Inc. showing signs of accumulation2025 Fundamental Recap & Short-Term High Return Strategies - newser.com
Published on: 2025-09-19 05:51:52 - newser.com
History Review: Whats the outlook for JPMorgan Chase Cos sector2025 Volume Leaders & High Yield Equity Trading Tips - khodrobank.com
Sectors Review: Will Collegium Pharmaceutical Inc benefit from green energy policies2025 Geopolitical Influence & Verified Technical Trade Signals - khodrobank.com
13,660 Shares in Collegium Pharmaceutical, Inc. $COLL Purchased by Belpointe Asset Management LLC - MarketBeat
Collegium Pharmaceutical Inc. stock retracement – recovery analysisWeekly Gains Report & Verified Momentum Stock Alerts - newser.com
Applying sector rotation models to Collegium Pharmaceutical Inc.Trade Risk Summary & Reliable Entry Point Trade Alerts - newser.com
Amundi Has $1.82 Million Position in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Aug EndMonth: Will Silvercrest Asset Management Group Inc. outperform tech stocksWeekly Investment Recap & Consistent Growth Stock Picks - خودرو بانک
Relative strength of Collegium Pharmaceutical Inc. in sector analysisEarnings Beat & Precise Buy Zone Identification - newser.com
Big Picture: Is Collegium Pharmaceutical Inc. a stock for growth or value investorsQuarterly Profit Report & Community Verified Trade Signals - خودرو بانک
Take Profit: What dividend growth rate does Collegium Pharmaceutical Inc offerTrade Performance Summary & Technical Analysis for Trade Confirmation - خودرو بانک
Chart overlay techniques for tracking Collegium Pharmaceutical Inc.2025 Performance Recap & Advanced Swing Trade Entry Plans - newser.com
Analysis Recap: What is the PEG ratio of Collegium Pharmaceutical Inc2025 Market Overview & Comprehensive Market Scan Reports - خودرو بانک
Chronic Lower Back Pain Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment | Collegium Pharma, Eli Lilly and Company, Camurus/Braeburn Inc., Scilex Holding - The Globe and Mail
Fortis Capital Advisors LLC Acquires Shares of 13,660 Collegium Pharmaceutical, Inc. $COLL - MarketBeat
How to recover losses in Collegium Pharmaceutical Inc. stockQuarterly Portfolio Review & Entry Point Confirmation Signals - newser.com
Dow Update: What is the target price for Collegium Pharmaceutical Inc stockTrade Signal Summary & Verified Momentum Stock Alerts - خودرو بانک
Published on: 2025-09-16 22:00:53 - خودرو بانک
Earnings Recap: Is EXPI trading at a discountEarnings Miss & Risk Managed Investment Signals - خودرو بانک
Aug Levels: Is Collegium Pharmaceutical Inc trading at a discountWeekly Trade Review & AI Driven Stock Movement Reports - خودرو بانک
Rhumbline Advisers Acquires 3,400 Shares of Collegium Pharmaceutical, Inc. $COLL - Defense World
Q2 Earnings Roundup: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Segment - Yahoo Finance
Nasdaq Moves: What is the PEG ratio of Collegium Pharmaceutical IncQuarterly Portfolio Summary & Safe Capital Growth Trade Ideas - خودرو بانک
Weekly Earnings: Is Collegium Pharmaceutical Inc. stock a good pick for beginnersCEO Change & AI Optimized Trading Strategy Guides - خودرو بانک
Exit strategy if you’re trapped in Collegium Pharmaceutical Inc.2025 Macro Impact & Daily Volume Surge Signals - newser.com
Can a trend reversal in Collegium Pharmaceutical Inc. lead to recoveryStop Loss & Intraday High Probability Setup Alerts - newser.com
Finanzdaten der Collegium Pharmaceutical Inc-Aktie (COLL)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):